Page last updated: 2024-10-31

neostigmine and Anal Cancer

neostigmine has been researched along with Anal Cancer in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research Excerpts

ExcerptRelevanceReference
"Undertreated myasthenia gravis can lead to a rapid deterioration in a patient's clinical condition, and such patients may be mistakenly diagnosed as dying."5.56Administering Neostigmine as a Subcutaneous Infusion: A Case Report of a Patient Dying With Myasthenia Gravis. ( Hindmarsh, J; Lee, M; Pickard, J; Woods, E, 2020)
"Undertreated myasthenia gravis can lead to a rapid deterioration in a patient's clinical condition, and such patients may be mistakenly diagnosed as dying."1.56Administering Neostigmine as a Subcutaneous Infusion: A Case Report of a Patient Dying With Myasthenia Gravis. ( Hindmarsh, J; Lee, M; Pickard, J; Woods, E, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hindmarsh, J1
Woods, E1
Lee, M1
Pickard, J1

Other Studies

1 other study available for neostigmine and Anal Cancer

ArticleYear
Administering Neostigmine as a Subcutaneous Infusion: A Case Report of a Patient Dying With Myasthenia Gravis.
    Journal of palliative care, 2020, Volume: 35, Issue:2

    Topics: Aged, 80 and over; Anus Neoplasms; Cholinesterase Inhibitors; Fatal Outcome; Humans; Infusions, Subc

2020